IFNG and myeloid sarcoma: Specifically, in the context of neuroinflammation, cells characterised by the expression of TNF, IFN-γ, IL-2, the CXC chemokine receptor type 4 (CXCR4) and very late antigen 4 (VLA4) were convergent in the blood of patients with MS.